Match!

The clinical phenotype of Graves’ disease occurring as an isolated condition or in association with other autoimmune diseases

Published on Feb 1, 2020in Journal of Endocrinological Investigation
· DOI :10.1007/s40618-019-01094-7
Mario Rotondi43
Estimated H-index: 43
,
Camilla Virili13
Estimated H-index: 13
(Sapienza University of Rome)
+ 5 AuthorsLuca Chiovato48
Estimated H-index: 48
Abstract
Purpose Graves’ disease (GD) can present as an isolated disease (iGD) or in association with other autoimmune diseases (aGD). The aim of this study, performed in two Endocrine referral centers settled in different geographical areas of Italy, was to compare the anthropometric, clinical, and biochemical phenotype of iGD patients with that of the aGD ones.
  • References (47)
  • Citations (0)
📖 Papers frequently viewed together
19810.64Cutis
2 Authors (Wolf R, Feuerman Ej)
25 Citations
8 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References47
Newest
#1Silvia Ferrari (UniPi: University of Pisa)H-Index: 36
#2Poupak Fallahi (UniPi: University of Pisa)H-Index: 44
Last. Alessandro Antonelli (UniPi: University of Pisa)H-Index: 56
view all 7 authors...
8 CitationsSource
5 CitationsSource
#1Mario Rotondi (UNIPV: University of Pavia)H-Index: 43
#2Valentina CapelliH-Index: 6
Last. Luca Chiovato (UNIPV: University of Pavia)H-Index: 48
view all 7 authors...
2 CitationsSource
Autoimmune Polyendocrine Syndromes Autoimmune polyendocrine syndromes comprise a diverse group of clinical entities involving functional impairment of multiple endocrine glands due to loss of immune tolerance. This article reviews recent discoveries as well as approaches to the care of affected patients.
39 CitationsSource
2 CitationsSource
#1Tristan StrujaH-Index: 4
#2Marina KaeslinH-Index: 1
Last. Philipp SchuetzH-Index: 49
view all 17 authors...
13 CitationsSource
21 CitationsSource
#1Jia LiuH-Index: 1
#2Jing FuH-Index: 2
Last. Guang WangH-Index: 1
view all 4 authors...
Graves’ disease (GD) is the most common cause of hyperthyroidism worldwide. Current therapeutic options for GD include antithyroid drugs (ATD), radioactive iodine, and thyroidectomy. ATD treatment is generally well accepted by patients and clinicians due to some advantages including normalizing thyroid function in a short time, hardly causing hypothyroidism, and ameliorating immune disorder while avoiding radiation exposure and invasive procedures. However, the relatively high recurrence rate is...
9 CitationsSource
#1L. Bartelena (University of Insubria)H-Index: 55
#2E. Masiello (University of Insubria)H-Index: 4
Last. Luca Chiovato (UNIPV: University of Pavia)H-Index: 48
view all 15 authors...
Objective The Merseburg triad (hyperthyroidism, goiter, and orbitopathy) characterizes classical description of Graves’ disease (GD). Aim of this observational, longitudinal study was to evaluate the current clinical features of newly diagnosed GD in Italy.
18 CitationsSource
#1Syed A. Morshed (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 12
#2Terry F. Davies (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 70
The immunologic processes involved in Graves’ disease (GD) have one unique characteristic – the autoantibodies to the TSH receptor (TSHR) – which have both linear and conformational epitopes. Three types of TSHR antibodies (stimulating, blocking, and cleavage) with different functional capabilities have been described in GD patients, which induce different signaling effects varying from thyroid cell proliferation to thyroid cell death. The establishment of animal models of GD by TSHR antibody tr...
33 CitationsSource
Cited By0
Newest
#1A. Ponzetto (UNITO: University of Turin)
#2N. Figura (UNISI: University of Siena)
Source